Home/Filings/4/0001235802-23-000069
4//SEC Filing

Wambeke David J. 4

Accession 0001235802-23-000069

CIK 0001401040other

Filed

Jun 25, 8:00 PM ET

Accepted

Jun 26, 4:14 PM ET

Size

4.6 KB

Accession

0001235802-23-000069

Insider Transaction Report

Form 4
Period: 2023-06-23
Wambeke David J.
Chief Business Officer
Transactions
  • Purchase

    Voting Common Shares, no par value per share

    2023-06-23$3.91/sh+38,364$150,003507,114 total

Issuer

DiaMedica Therapeutics Inc.

CIK 0001401040

Entity typeother

Related Parties

1
  • filerCIK 0001971798

Filing Metadata

Form type
4
Filed
Jun 25, 8:00 PM ET
Accepted
Jun 26, 4:14 PM ET
Size
4.6 KB